SC: Centre's nod for Remdesivir and Favipiravir for Covid-19, asks petitioner to study rules
Published By : Prameya News Bureau | September 16, 2020 IST
Share
New Delhi, Sep 16: The Supreme Court on Wednesday said the Centre has framed rules on drugs clinical trial and there is also an approval on the use of Remdesivir and Favipiravir as medicines to treat Covid-19.A bench headed by Chief Justice S A Bobde and comprising Justices A S Bopanna and V Ramasubramanian, citing the New Drugs and Clinical Trials Rules, 2018, said these medicines have been permitted by the government for the Covid-19 pandemic situation.The observation came from the top court while hearing a plea a seeking CBI probe against 10 pharma companies selling these medicines allegedly as a treatment for Covid-19 patients without valid licences.Both Remdesivir and Favipiravir are antiviral drugs and their clinical efficacy in the treatment of the Covid-19 viral infection is a matter of debate.The bench told the petitioner that it seems he has not noticed New Drugs and Clinical Trials Rules and filed this plea before the court. "You may see the rules and come back to the court. We are adjourning this matter", the bench told advocate M L Sharma, who filed this plea.The bench has adjourned the matter for two weeks.The plea contended," That respondent no.3 to 10 are Indian pharmaceutical company who have signed partnership agreements with foreign companies that are Gilead Science Inc -USA and Fujifilm Japan, to manufacture and sale impugned drug, Remdesivir and Avagin (Favipiravir) in India. Without having a licence, they are manufacturing and selling impugned drugs as a medicine for corona in India."Seeking a CBI probe, the petitioner alleged that these two medicines have been wrongly manufactured and sold in the garb of treatment for Covid-19 patients without any valid licences from the Central Drugs Standard Control Organisation.The petitioner sought prosecution of Indian companies for offences of cheating and criminal conspiracy besides under the provisions of the Drug Act, 1940. (IANS)
News7 Is Now On WhatsApp Join And Get Latest News Updates Delivered To You Via WhatsApp
You Might Also Like
More From Related News
LS polls 2024: PM Modi to campaign in UP, MP and Maharashtra today
Vice-Admiral Dinesh Tripathi appointed as new Navy Chief
Lok Sabha Elections 2024: Tamil Superstar Ajith Kumar sets early example by voting
Vice-Admiral Dinesh Kumar Tripathi appointed as next Chief of Naval Staff
Polling begins for Tripura West Lok Sabha Seat and Ramnagar Assembly By-Polls
Nagaland LS Election 2024: Voting commences amidst security measures
Virat Kohli's statue installed at Jaipur Wax Museum on World Heritage Day
Punjab electoral officer to go Live for election-related queries
Jilted lover stabs corporator's daughter to death in Karnataka college campus
Nestle baby food sugar study causes concern in India, Nestle India's shares fall
'Yamraj' files nomination as Independent for Maharashtra's Madha LS seat
ED reveals Kejriwal's high glycaemic index diet plan, AAP alleges political vendetta
Suprme Court reserves verdict on pleas seeking mandatory EVM-VVPAT tally
LS poll: BJP nominates Narayan Rane from Ratnagiri Sindhudurg
ED attaches Shilpa Shetty and Raj Kundra's assets worth Rs 98 Cr
FIR filed against woman accusing Ravi Kishan is father of her daughter
Kashi sculptor's replica of Ram Lalla idol for Netherlands Temple
Lok Sabha polls: More rallies, roadshows planned for PM Modi in UP
Over 25 Million voters set to cast ballots in Rajasthan's first phase of Lok Sabha Elections
Political controversy erupts over attack on youths chanting 'Jai Shri Ram' in Bengaluru